
Journal of International Oncology ›› 2026, Vol. 53 ›› Issue (2): 87-92.doi: 10.3760/cma.j.cn371439-20250607-00013
• Original Article • Previous Articles Next Articles
Arya Ehmet1, Nuriman Samat2, Wang Tingting1(
)
Received:2025-06-07
Online:2026-02-08
Published:2026-01-29
Contact:
Wang Tingting
E-mail:smile202022@163.com
Supported by:Arya Ehmet, Nuriman Samat, Wang Tingting. Analysis of the correlation between nutritional status and preoperative gastric morphology and functional characteristics in patients with gastric cancer after radical gastrectomy[J]. Journal of International Oncology, 2026, 53(2): 87-92.
"
| 项目 | 流出组 (n=51) | 留存组 (n=83) | t/χ2值 | P值 |
|---|---|---|---|---|
| 年龄(岁,$\bar{x}±s$) | 62.19±5.23 | 63.24±5.13 | 1.14 | 0.258 |
| 性别[例(%)] | ||||
| 男 | 33(64.71) | 52(62.65) | 0.06 | 0.811 |
| 女 | 18(35.29) | 31(37.35) | ||
| TNM分期[例(%)] | ||||
| Ⅰ期 | 9(17.65) | 24(28.92) | 2.16 | 0.155 |
| Ⅱ期 | 42(82.35) | 59(71.08) | ||
| 吸烟史[例(%)] | ||||
| 是 | 18(35.29) | 27(32.53) | 0.11 | 0.742 |
| 否 | 33(64.71) | 56(67.47) | ||
| 淋巴结转移[例(%)] | ||||
| 是 | 4(7.84) | 6(7.23) | <0.01 | >0.999 |
| 否 | 47(92.16) | 77(92.77) | ||
| 分化程度[例(%)] | ||||
| 低分化 | 8(15.69) | 9(10.84) | 1.18 | 0.555 |
| 中分化 | 14(27.45) | 29(34.94) | ||
| 高分化 | 29(56.86) | 45(54.22) | ||
| 浸润深度[例(%)] | ||||
| 黏膜上皮及固有层 | 11(21.57) | 17(20.48) | 0.08 | 0.962 |
| 黏膜肌层 | 13(25.49) | 20(24.10) | ||
| 黏膜下层 | 27(52.94) | 46(55.42) | ||
| 病灶最大径(cm,$\bar{x}±s$) | 2.04±0.37 | 2.09±0.31 | 0.81 | 0.421 |
| 丙氨酸氨基转移酶 (U/L,$\bar{x}±s$) | 37.23±4.52 | 36.44±4.13 | 1.01 | 0.312 |
| 总胆红素(mmol/L, $\bar{x}±s$) | 11.03±2.12 | 11.52±2.09 | 1.31 | 0.194 |
| 肌酐(μmol/L,$\bar{x}±s$) | 62.31±9.83 | 63.47±8.24 | 0.70 | 0.483 |
| 血清白蛋白(g/L,$\bar{x}±s$) | 43.03±4.07 | 41.76±4.09 | 1.75 | 0.082 |
| 血红蛋白(g/L,$\bar{x}±s$) | 125.39±18.52 | 120.24±19.47 | 1.53 | 0.128 |
"
| 项目 | 流出组(n=51) | 留存组(n=83) | t值 | P值 |
|---|---|---|---|---|
| BMI | ||||
| 术前1周 | 21.29±1.21 | 21.09±1.36 | 0.89 | 0.378 |
| 术后1个月 | 20.75±1.82 | 20.25±1.24a | 1.73 | 0.087 |
| 下降率(%) | 3.62±0.49 | 3.94±0.48 | 3.67 | <0.001 |
| 去脂BMI | ||||
| 术前1周 | 15.29±1.07 | 15.31±1.08 | 0.10 | 0.916 |
| 术后1个月 | 14.68±0.94a | 14.36±0.88a | 1.88 | 0.062 |
| 下降率(%) | 3.75±0.51 | 4.06±0.47 | 3.52 | <0.001 |
| 脂肪指数 | ||||
| 术前1周 | 5.98±0.92 | 5.84±0.83 | 0.89 | 0.378 |
| 术后1个月 | 5.77±0.93 | 5.58±0.72a | 1.25 | 0.215 |
| 下降率(%) | 3.54±0.43 | 3.82±0.49 | 3.47 | <0.001 |
| 骨骼肌指数 | ||||
| 术前1周 | 10.13±1.02 | 10.23±1.98 | 0.38 | 0.701 |
| 术后1个月 | 9.51±1.12a | 9.46±1.57a | 0.64 | 0.520 |
| 下降率(%) | 3.76±0.53 | 4.01±0.48 | 2.75 | 0.007 |
| 无机盐指数 | ||||
| 术前1周 | 5.01±0.98 | 4.94±0.81 | 0.43 | 0.669 |
| 术后1个月 | 5.00±0.89 | 4.99±0.73 | 0.07 | 0.946 |
| 下降率(%) | 0.14±0.05 | 0.13±0.04 | 1.21 | 0.229 |
"
| 因素 | 未标准化系数 | 标准化系数 | P值 | |||
|---|---|---|---|---|---|---|
| β值 | SE值 | β值 | t值 | |||
| 常量 | 3.66 | 0.90 | 4.09 | <0.001 | ||
| 胃形态学分类 | -0.25 | 0.09 | -0.26 | -2.90 | 0.005 | |
| 年龄 | 0.01 | 0.01 | 0.07 | 0.71 | 0.477 | |
| 病灶直径 | -0.17 | 0.13 | -0.12 | -1.35 | 0.178 | |
| 丙氨酸氨基转移酶 | <0.01 | 0.01 | -0.04 | -0.47 | 0.641 | |
| 总胆红素 | -0.01 | 0.02 | -0.04 | -0.44 | 0.663 | |
| 肌酐 | 0.01 | 0.01 | 0.14 | 1.56 | 0.120 | |
| 性别构成 | 0.02 | 0.08 | 0.02 | 0.23 | 0.822 | |
| 吸烟史 | 0.12 | 0.09 | 0.12 | 1.35 | 0.181 | |
| TNM分期 | -0.08 | 0.11 | -0.07 | -0.76 | 0.451 | |
| 淋巴结转移 | -0.03 | 0.15 | -0.02 | -0.21 | 0.831 | |
| 分化程度 | 0.01 | 0.06 | 0.01 | 0.15 | 0.882 | |
| 浸润深度 | -0.05 | 0.05 | -0.09 | -1.01 | 0.313 | |
| 血红蛋白 | <0.01 | <0.01 | -0.10 | -1.05 | 0.297 | |
| 血清白蛋白 | 0.01 | 0.01 | 0.07 | 0.75 | 0.454 | |
"
| 因素 | 未标准化系数 | 标准化系数 | P值 | |||
|---|---|---|---|---|---|---|
| β值 | SE值 | β值 | t值 | |||
| 常量 | 2.60 | 0.91 | 2.86 | 0.005 | ||
| 胃形态学分类 | -0.39 | 0.09 | -0.38 | -4.50 | <0.001 | |
| 年龄 | <0.01 | 0.01 | 0.02 | 0.23 | 0.819 | |
| 病灶直径 | 0.19 | 0.13 | 0.13 | 1.50 | 0.138 | |
| 丙氨酸氨基转移酶 | 0.01 | 0.01 | 0.10 | 1.21 | 0.228 | |
| 总胆红素 | <0.01 | 0.02 | 0.01 | 0.08 | 0.935 | |
| 肌酐 | <0.01 | 0.01 | -0.02 | -0.26 | 0.800 | |
| 性别构成 | 0.02 | 0.09 | 0.02 | 0.21 | 0.834 | |
| 吸烟史 | -0.11 | 0.09 | -0.11 | -1.24 | 0.217 | |
| TNM分期 | 0.17 | 0.11 | 0.13 | 1.51 | 0.135 | |
| 淋巴结转移 | -0.03 | 0.16 | -0.02 | -0.19 | 0.850 | |
| 分化程度 | -0.09 | 0.06 | -0.12 | -1.43 | 0.155 | |
| 浸润深度 | 0.01 | 0.05 | 0.01 | 0.14 | 0.885 | |
| 血红蛋白 | <0.01 | <0.01 | -0.06 | -0.64 | 0.525 | |
| 血清白蛋白 | 0.02 | 0.01 | 0.17 | 2.01 | 0.047 | |
| [1] | Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648. DOI: 10.1016/S0140-6736(20)31288-5. |
| [2] | 伍杨, 李甜, 张润兵, 等. 胃癌及食管胃结合部癌免疫及靶向治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(9): 595-600. DOI: 10.3760/cma.j.cn371439-20240716-00099. |
| [3] |
Park YS, Park DJ, Kim KH, et al. Nutritional safety of oncometabolic surgery for early gastric cancer patients: a prospective single-arm pilot study using a historical control group for comparison[J]. Surg Endosc, 2020, 34(1): 275-283. DOI: 10.1007/s00464-019-06763-5.
pmid: 30927123 |
| [4] |
Camilleri M. Peripheral mechanisms in appetite regulation[J]. Gastroenterology, 2015, 148(6): 1219-1233. DOI: 10.1053/j.gastro.2014.09.016.
pmid: 25241326 |
| [5] | 中国临床肿瘤学会(CSCO). 胃癌诊疗指南(2019)[M]. 北京: 人民卫生出版社, 2019. |
| [6] | 叶剑锋. 局限性肾癌的外科治疗进展[J]. 国际泌尿系统杂志, 2013, 33(4): 511-514. DOI: 10.3760/cma.j.issn.1673-4416.2013.04.027. |
| [7] |
Nagasawa S, Tanabe M, Onuma S, et al. Effect of preoperative gastric shape on loss of lean body mass after distal gastrectomy[J]. In Vivo, 2024, 38(1): 445-452. DOI: 10.21873/invivo.13458.
pmid: 38148040 |
| [8] | 中国抗癌协会肿瘤营养专业委员会,中华医学会肠外肠内营养学分会. 胃癌患者的营养治疗专家共识[J]. 肿瘤代谢与营养电子杂志, 2023, 10(2): 208-212. DOI: 10.16689/j.cnki.cn11-9349/r.2023.02.008. |
| [9] | 姬薇, 关泉林, 陈雅蕊, 等. 血脂水平与胃癌的相关性[J]. 国际肿瘤学杂志, 2023, 50(3): 183-185. DOI: 10.3760/cma.j.cn371439-20221103-00036. |
| [10] | Xie K, He D, Zhao T, et al. Gastric cancer with sarcopenia: an area worth focusing on[J]. Curr Treat Options Oncol, 2023, 24(10): 1305-1327. DOI: 10.1007/s11864-023-01122-y. |
| [11] |
Waki Y, Irino T, Makuuchi R, et al. Impact of preoperative skeletal muscle quality measurement on long-term survival after curative gastrectomy for locally advanced gastric cancer[J]. World J Surg, 2019, 43(12): 3083-3093. DOI: 10.1007/s00268-019-05145-1.
pmid: 31482345 |
| [12] | Capuano E, Janssen AEM. Food matrix and macronutrient digestion[J]. Annu Rev Food Sci Technol, 2021, 12: 193-212. DOI: 10.1146/annurev-food-032519-051646. |
| [13] | Ishikawa Y, Chang AC, Lin J, et al. Wider gastric conduit morphology is associated with improved blood flow during esophagectomy[J]. J Gastrointest Surg, 2023, 27(5): 845-854. DOI: 10.1007/s11605-022-05530-7. |
| [14] | Peng Z, Wu P, Wang J, et al. Achieving realistic gastric emptying curve in an advanced dynamic in vitro human digestion system: experiences with cheese—a difficult to empty material[J]. Food Funct, 2021, 12(9): 3965-3977. DOI: 10.1039/d0fo03364b. |
| [15] | Wang YJ, Hung KL, Yang JN, et al. Gastric anatomic type is associated with obesity and gender[J]. Obes Facts, 2016, 9(3): 221-229. DOI: 10.1159/000445062. |
| [16] | Cheng SM, Hung KL, Wang YJ, et al. Influence of gastric morphology on gastroesophageal reflux in adults: an observational study[J]. Medicine (Baltimore), 2021, 100(38): e27241. DOI: 10.1097/MD.0000000000027241. |
| [17] | 肖潇, 胡松, 季晓云, 等. 80岁及以上住院患者肌肉减少症与营养状况的相关性分析[J]. 中华老年医学杂志, 2019, 38(6): 654-657. DOI: 10.3760/cma.j.issn.0254-9026.2019.06.014. |
| [18] | 岳亚玲, 江丽强, 田遂, 等. 血清肉碱与结直肠癌放疗患者肌肉减少及营养状况的相关性[J]. 肿瘤代谢与营养电子杂志, 2022, 9(4): 481-486. DOI: 10.16689/j.cnki.cn11-9349/r.2022.04.013. |
| [19] |
Scarpellini E, Arts J, Karamanolis G, et al. International consensus on the diagnosis and management of dumping syndrome[J]. Nat Rev Endocrinol, 2020, 16(8): 448-466. DOI: 10.1038/s41574-020-0357-5.
pmid: 32457534 |
| [20] |
van Beek AP, Emous M, Laville M, et al. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management[J]. Obes Rev, 2017, 18(1): 68-85. DOI: 10.1111/obr.12467.
pmid: 27749997 |
| [1] | Laibijiang Wusiman, Song Dingding, Zhang Wenbin. Effect of SPART on the proliferation and migration capabilities of gastric cancer cell through lipophagy [J]. Journal of International Oncology, 2026, 53(2): 73-78. |
| [2] | Wang Yu, Li Yuanfei, Guo Yuntong. Research progress of the immunoscore system in gastric cancer [J]. Journal of International Oncology, 2026, 53(1): 62-64. |
| [3] | Li Guangxin, Quan Huijuan, Gao Zhijuan, Wang Xiaojun, Li Liang, Dong Qian, Miao Yongtao, Liu Dongsheng. Correlation between serum levels of HAMP, SPP1, RGS2 and clinical pathological characteristics of gastric cancer patients and their predictive value for postoperative recurrence or metastasis [J]. Journal of International Oncology, 2025, 52(8): 502-507. |
| [4] | Liu Qianyi, Dong Hongmin, Wang Wenling, Wang Gang, Chen Wanghua. Clinical efficacy and safety of radiotherapy combined with chemotherapy and immunotherapy for HER2-negative locally advanced or advanced gastric cancer [J]. Journal of International Oncology, 2025, 52(4): 209-216. |
| [5] | Ji Haitao, Wang Yanfeng, Liu Yongcheng, Hao Nan. Expression and clinical significance of DHCR7 in gastric cancer based on bioinformatics analysis [J]. Journal of International Oncology, 2025, 52(2): 94-100. |
| [6] | Liu Pingping, Wang Junyi, Lin Zhiwei, Chen Dachao. Analysis of factors influencing the prognosis of patients with postoperative peritoneal metastasis of gastric cancer [J]. Journal of International Oncology, 2025, 52(12): 764-769. |
| [7] | Zhang Shuai, Liu Liangliang, Huang Di, Sheng Ru, Qi Mengyao, Li Shuguang. Effects of circRNA-15430 targeting miR-10 on proliferation and invasion of gastric cancer cells [J]. Journal of International Oncology, 2025, 52(11): 673-679. |
| [8] | Tan Rongjian, Ou Wenting, Zhai Jiawei, Quan Zhenhao, Sun Lijun, Zhou Caijin. Effects of RRM2 on malignant biological behavior and aerobic glycolysis of gastric cancer cells by regulating CDK1 [J]. Journal of International Oncology, 2025, 52(1): 23-30. |
| [9] | Wu Yang, Li Tian, Zhang Runbing, Shi Tingting, Gao Chun, Zheng Xiaofeng, Zhang Jiucong. Research progress in immunotherapy and targeted therapy for gastric cancer and esophagogastric junction cancer [J]. Journal of International Oncology, 2024, 51(9): 595-600. |
| [10] | Liu Wenhui, Yin Ping, Qi Jie. Diagnostic value of detection of serum G-17,sB7-H3,and DKK1 for early gastric cancer [J]. Journal of International Oncology, 2024, 51(8): 498-503. |
| [11] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
| [12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. |
| [13] | Xie Shuping, Sun Yahong, Wang Chao. Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer [J]. Journal of International Oncology, 2024, 51(3): 157-165. |
| [14] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan. Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer [J]. Journal of International Oncology, 2024, 51(3): 175-180. |
| [15] | Shao Huifang, Wang Xuehong, Lu Yongfu. Mechanism of action and clinical significance of CST1 in the progression of gastric cancer [J]. Journal of International Oncology, 2023, 50(8): 489-492. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||